Triple therapy reduced mortality more than oseltamivir alone in patients admitted for severe influenza infection

Ann Intern Med. 2017 Oct 17;167(8):JC41. doi: 10.7326/ACPJC-2017-167-8-041.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents
  • Hospitalization
  • Humans
  • Influenza A Virus, H1N1 Subtype
  • Influenza, Human*
  • Oseltamivir*

Substances

  • Antiviral Agents
  • Oseltamivir